NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
4.150
+0.130 (3.23%)
At close: Mar 9, 2026, 4:00 PM EDT
3.980
-0.170 (-4.10%)
After-hours: Mar 9, 2026, 5:33 PM EDT
NervGen Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 329 | 153 | 122 | 69 | 98 | 61 | |
| Market Cap Growth | 129.71% | 25.91% | 75.67% | -29.11% | 59.23% | 38.56% | |
| Enterprise Value | 321 | 139 | 111 | 49 | 91 | 55 | |
| Last Close Price | 4.15 | 2.18 | 2.04 | 1.19 | 2.13 | 1.74 | |
| PB Ratio | - | 85.68 | -80.10 | 6.98 | 7.36 | 13.23 | |
| P/TBV Ratio | - | 104.55 | - | 7.21 | 7.58 | 14.37 | |
| Debt / Equity Ratio | -0.01 | 0.04 | -0.10 | 0.02 | - | - | |
| Net Debt / Equity Ratio | 3.85 | -6.66 | 5.71 | -1.65 | -1.01 | -0.95 | |
| Net Debt / EBITDA Ratio | 0.45 | 0.69 | 0.65 | 0.97 | 1.33 | 0.50 | |
| Net Debt / FCF Ratio | 0.68 | 1.02 | 1.01 | 1.25 | 2.05 | 0.89 | |
| Quick Ratio | 0.73 | 1.05 | 0.79 | 2.20 | 15.76 | 7.50 | |
| Current Ratio | 0.79 | 1.13 | 0.83 | 2.27 | 16.16 | 8.21 | |
| Return on Equity (ROE) | -820.11% | -8460.20% | -390.89% | -136.87% | -111.94% | -190.21% | |
| Return on Assets (ROA) | -88.77% | -95.24% | -59.88% | -68.90% | -65.17% | -104.12% | |
| Return on Capital Employed (ROCE) | 857.90% | -964.50% | 933.90% | -168.60% | -76.20% | -189.10% | |
| Earnings Yield | -5.57% | -10.87% | -13.91% | -22.07% | -10.28% | -14.28% | |
| FCF Yield | -3.75% | -7.63% | -7.02% | -18.96% | -6.68% | -8.05% | |
| Buyback Yield / Dilution | -10.41% | -13.55% | -12.61% | -34.00% | -22.35% | -23.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.